In case you missed it, we recently announced our partnerships with McRoberts BV and Mobilise-D , integrating their digital endpoints and outcomes into our platform. The integration of third party algorithms in a pre-existing solution provides a range of benefits for clinical trial sponsors, including: ✅ Use your preferred endpoint in your study ✅ Monitor different biomarkers from a single solution ✅ Reduce your operational costs and the burden on patients, only needing to use one device and app ✅ Simplify and streamline your training processes, with training only needed for one solution #WearableTechnology #DigitalBiomarkers
Empatica’s Post
More Relevant Posts
-
Discover the most comprehensive view of hundreds of millions of patient journeys with the nation’s largest fully interoperable, de-identified healthcare and consumer data ecosystem. HealthVerity Marketplace allows you to build custom patient cohorts based on expansive healthcare criteria, such as diagnosis, drug, procedure, lab test or biomarker. Start discovering today https://hubs.ly/Q02gk0RS0
-
Life Sciences Market Access and Commercial Strategy partner/ Diagnostics / Digital Health / Integrated solutions / Business development
Perfect timing for our webinar coming up next week April 24th. ⌚ Just days away from the news that Click Therapeutics and Otsuka secured FDA clearance for the first prescription digital program designed for adults with major depressive disorder (#MDD) Charles River Associates is holding a webinar on #digitaltherapeutics with the participation of Click Therapeutics, Inc. and DarioHealth Join to understand the challenges, the success factors and the latest trends on business models in #digitalhealth
Join us for an interactive panel discussion with leaders in Digital Therapeutics featuring Richard DeNunzio, CCO, Click Therapeutics, Omar Manejwala, M.D., CMO, Dario Health, and Brion Raymond, CBO, Luminopia. Learn how key players are reacting to emerging challenges, and which business models they are exploring and tailoring to the needs of payers, providers, patients and other stakeholders. #CRALifeSciences Andy Parece and Rhett Johnson moderate the session – click here to learn more and register: https://lnkd.in/gjdbCBTd #DigitalTherapeutics
-
-
Exciting to share the below webinar #CRALifeSciences is hosting in a couple of weeks' time on the evolving business models in digital therapeutics. See the link to learn more and register! #DigitalTherapeutics
Join us for an interactive panel discussion with leaders in Digital Therapeutics featuring Richard DeNunzio, CCO, Click Therapeutics, Omar Manejwala, M.D., CMO, Dario Health, and Brion Raymond, CBO, Luminopia. Learn how key players are reacting to emerging challenges, and which business models they are exploring and tailoring to the needs of payers, providers, patients and other stakeholders. #CRALifeSciences Andy Parece and Rhett Johnson moderate the session – click here to learn more and register: https://lnkd.in/gjdbCBTd #DigitalTherapeutics
-
-
Dive into the world of biosimilars with CareMetx Executive Chairman, Mark Hansan, as he discusses how these innovative therapies are enhancing patient access and overcoming challenges. https://hubs.la/Q02mTWQF0
-
-
The growing focus on early-stage pipelines across the industry reflects a collective commitment to addressing areas of significant unmet medical need. Astellas leaders shared their perspectives with Endpoints News on how #Research, Business Development teams, and external partners, need to be more connected than ever to unlock the potential of next-generation therapies for patients. Read more: https://bit.ly/47js339 #ScienceFirstForPatients #ChangingTomorrow
-
🔬 𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: 𝐀 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐂𝐋𝐒𝐈 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬 🔬 In our newest blog, our Principal Consultant IVD, Dr. Sebastian Grömminger, explores the vital impact of #CLSI Evaluation Protocols on #invitrodiagnostics. Discover the transformative power of rigorous performance evaluations and their role in advancing clinical evidence and patient care. Embark on this insightful journey: https://lnkd.in/d7BKGrYJ #IVD #Clinicalevidence #clinicaldiagnostics
-
-
CLSI guidelines have become an essential part when it comes to the state-of-the-art of analytical performance for IVDs. We are happy to share some valuable information helping you how to approach that challenge. Please feel free to reach out to us ! #oneentourage #ivdr #clinicalevidence
🔬 𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: 𝐀 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐂𝐋𝐒𝐈 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬 🔬 In our newest blog, our Principal Consultant IVD, Dr. Sebastian Grömminger, explores the vital impact of #CLSI Evaluation Protocols on #invitrodiagnostics. Discover the transformative power of rigorous performance evaluations and their role in advancing clinical evidence and patient care. Embark on this insightful journey: https://lnkd.in/d7BKGrYJ #IVD #Clinicalevidence #clinicaldiagnostics
-
-
Senior Sales Consultant 🔹 Business Developer 🔹 Your solution partner to drive success 🔹 Empowering life science to uphold GxP compliance and boost efficiency 🔹
🗞️𝗘𝘅𝗰𝗹𝘂𝘀𝗶𝘃𝗲 𝘕𝗲𝘄𝘀! 🗞️ Discover our newest publication on Clinical Evidence for In Vitro Diagnostic (IVD). Meet our Principal Consultant, Dr. Sebastian Grömminger, from our dedicated MedTech team, ready to assist with any inquiries. Download your complimentary copy now by clicking the link below. We're eager to hear from you! 🚀 #IVD #teamEntourage #OneEntourage
🔬 𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐂𝐥𝐢𝐧𝐢𝐜𝐚𝐥 𝐃𝐢𝐚𝐠𝐧𝐨𝐬𝐭𝐢𝐜𝐬: 𝐀 𝐆𝐮𝐢𝐝𝐞 𝐭𝐨 𝐂𝐋𝐒𝐈 𝐏𝐫𝐨𝐭𝐨𝐜𝐨𝐥𝐬 🔬 In our newest blog, our Principal Consultant IVD, Dr. Sebastian Grömminger, explores the vital impact of #CLSI Evaluation Protocols on #invitrodiagnostics. Discover the transformative power of rigorous performance evaluations and their role in advancing clinical evidence and patient care. Embark on this insightful journey: https://lnkd.in/d7BKGrYJ #IVD #Clinicalevidence #clinicaldiagnostics
-
-
Meet the 2024 co-chairs for DTA's Patient Engagement Task Group, Tim Campellone, PhD of Woebot Health and Cate Layne of Propeller Health! In an effort to keep the patient centered in conversations about digital therapeutics, DTA and its Patient Engagement Task Group members seek to define best-in-class standards for involving the patient in the development and launch of digital therapeutics, and to uncover barriers to their adoption by patients, payers, and regulatory bodies worldwide. Learn more about DTA's Task Groups here: https://lnkd.in/gHiRhE3J #DTA #DTx #digitaltherapeutics #patientengagement
-
-
In this third of a four-part video series, learn how GE HealthCare can help address challenges faced in reaching more patients who may benefit from innovative therapies. https://lnkd.in/gAgGEm27 #medtechinnovation #biopharma #healthcareai
-
Discover more on Empatica’s 200+ digital biomarker offering, the largest range in research from a single wearable ➡️ https://bit.ly/3Wm1d8i